Suchergebnisse

Johnson & Johnson's JNJ medical devices segment, known as MedTech, offers products in the orthopedics, surgery, cardiovascular and vision markets. The MedTech segment accounts for around 36% of

Despite sharp declines in 2026, Intuitive Surgical ISRG and Abbott Laboratories ABT remain among the highest-quality names in MedTech. ISRG has declined 32.1% year to date, while ABT is down 20.1%

Intuitive Surgical ISRG is navigating an increasingly competitive robotic surgery landscape as domestic Chinese manufacturers, European innovators and large global medtech companies expand their

Johnson & Johnson JNJ delivered better-than-expected second-quarter 2026 results, supported by continued strength across its Innovative Medicine portfolio and steady MedTech execution. The

Medtech giant Johnson & Johnson JNJ reported better-than-expected second-quarter 2026 results, surpassing Wall Street estimates on both the top and bottom lines. The quarterly performance was